Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Completed · Phase 1

Conditions studied: Oropharyngeal Candidiasis, Candidemia, Invasive Candidiasis, Esophageal Candidiasis

In brief

Children with fungal infections will be divided into two groups by weight. Children weighing \< 25 kg will receive a higher dose of study medication (per kg body weight) for 10 to 14 days than children weighing \> 25 kg.

Key facts

Study ID
NCT00608335
Run by
Astellas Pharma Inc
People needed
84
Starts
2007-10-14
Expected to finish
2011-09-08
Last updated by the study team
2024-11-18

Who can join

Age: 2 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.